Inventor · disambiguated record
Sidi Chen
Also filed as: CHEN SIDI
5 granted patents·14 pending applications·16 citations·filing 2017–2023
67Inventor score
Top patents by PatentIndex Score
19 records- 0195US11124796B2Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for modeling competition of multiple cancer mutations in vivoBROAD INST INC·Filed 2017·Granted Sep 21, 2021·16 cites·11 claims
- 0264US2025161360A1Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacyUNIV YALE·Filed 2023·Application pending·0 cites
- 0360US2025177570A1Multiplexed repression of immunosuppressive genesUNIV YALE·Filed 2023·Application pending·0 cites
- 0459US2025228940A1Compositions and methods for efficient and stable genetic modification of eukaryotic cellsUNIV YALE·Filed 2023·Application pending·0 cites
- 0558US2025134987A1Compositions and methods for vaccination against pathogenic coronavirus species and variantsUNIV YALE·Filed 2022·Application pending·0 cites
- 0657US12297428B2Compositions for identification of membrane targets for enhancement of T cell activity against cancerUNIV YALE·Filed 2019·Granted May 13, 2025·0 cites·1 claims
- 0757US2024228595A1Methods for Monoclonal Antibody GenerationUNIV YALE·Filed 2022·Application pending·0 cites
- 0851US11926839B2Platform for T lymphocyte genome engineering and in vivo high-throughput screening thereofUNIV YALE·Filed 2018·Granted Mar 12, 2024·0 cites·3 claims
- 0950US12497611B2Compositions and methods for high-throughput activation screening to boost T cell effector functionUNIV YALE·Filed 2019·Granted Dec 16, 2025·0 cites·19 claims
- 1050US2022387626A1Compositions and methods comprising viral vector systems for multiplexed activation of endogenous genes as immunotherapy and viral-based immune-gene therapyUNIV YALE·Filed 2020·Application pending·0 cites
- 1149US2023302134A1Compositions and methods for engineering and selection of car t cells with desired phenotypesUNIV YALE·Filed 2021·Application pending·0 cites
- 1248US12116619B2CRISPR mediated in vivo modeling and genetic screening of tumor growth and metastasisBROAD INST INC·Filed 2017·Granted Oct 15, 2024·0 cites·18 claims
- 1343US2021388389A1Compositions and methods for rapid and modular generation of chimeric antigen receptor t cellsUNIV YALE·Filed 2019·Application pending·0 cites
- 1441US2021113674A1Compositions and methods for multiplexed tumor vaccination with endogenous gene activationUNIV YALE·Filed 2019·Application pending·0 cites
- 1540US2021130818A1Compositions and Methods for Enhancement of Homology-Directed Repair Mediated Precise Gene Editing by Programming DNA Repair with a Single RNA-Guided EndonucleaseUNIV YALE·Filed 2018·Application pending·0 cites
- 1640US2022017715A1Compositions and Methods for Efficacy Enhancement of T-Cell Based ImmunotherapyDOW GLOBAL TECHNOLOGIES LLC·Filed 2018·Application pending·0 cites
- 1740US2020010903A1AAV-Mediated Direct In vivo CRISPR Screen in GlioblastomaUNIV YALE·Filed 2018·Application pending·0 cites
- 1838US2021139889A1Compositions and Methods for Multiplexed Genome Editing and ScreeningUNIV YALE·Filed 2018·Application pending·0 cites
- 1938US2020017917A1Mapping a Functional Cancer Genome Atlas of Tumor Suppressors Using AAV-CRISPR Mediated Direct In Vivo ScreeningUNIV YALE·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sidi Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →